Dual-Targeting Magnetic PLGA Nanoparticles for Codelivery of Paclitaxel and Curcumin for Brain Tumor Therapy

ACS Applied Materials and Interfaces

Volumn 8, Issue 47, 2016, Pages 32159-32169

  Cui, Yanna ^a,b   Zhang, Meng ^a   Zeng, Feng ^a,c,d   Jin, Hongyue ^a   Xu, Qin ^d   Huang, Yongzhuo ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b Chinese Academy of Sciences   (China)

^c FUDAN UNIVERSITY   (China)

^d GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

brain targeting delivery; curcumin; magnetic targeting; paclitaxel; PLGA nanoparticles; T7 peptide

Indexed keywords

CELL DEATH; CHEMOTHERAPY; MAGNETIC FIELD EFFECTS; MAGNETIC RESONANCE IMAGING; MAGNETISM; NANOPARTICLES; PEPTIDES; SYNCHROTRON RADIATION; TUMORS;

BRAIN TARGETING; CURCUMIN; MAGNETIC TARGETING; PACLITAXEL; PLGA NANOPARTICLES; T7 PEPTIDES;

NANOMAGNETICS;

CURCUMIN; LACTIC ACID; NANOPARTICLE; PACLITAXEL; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; DRUG DELIVERY SYSTEM; GLIOMA; MOUSE; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CURCUMIN; DRUG DELIVERY SYSTEMS; GLIOMA; LACTIC ACID; MICE; MICE, INBRED BALB C; NANOPARTICLES; PACLITAXEL; POLYGLYCOLIC ACID;

EID: 84999779316     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.6b10175     Document Type: Article

References (36)

1. Gallego, O. Nonsurgical Treatment of Recurrent Glioblastoma Curr. Oncol. 2015, 22, e273-e281 10.3747/co.22.2436
2. Wang, Z.; Sun, H.; Yakisich, J. S. Overcoming the Blood-Brain Barrier for Chemotherapy: Limitations, Challenges and Rising Problems Anti-Cancer Agents Med. Chem. 2014, 14, 1085-1093 10.2174/18715206113139990029
3. Spector, R. Nutrient Transport Systems in Brain: 40 Years of Progress J. Neurochem. 2009, 111, 315-320 10.1111/j.1471-4159.2009.06326.x
4. Allen, D. D.; Geldenhuys, W. J. Molecular Modeling of Blood-Brain Barrier Nutrient Transporters: in Silico Basis for Evaluation of Potential Drug Delivery to the Central Nervous System Life Sci. 2006, 78, 1029-1033 10.1016/j.lfs.2005.06.004
5. Mittapalli, R. K.; Manda, V. K.; Adkins, C. E.; Geldenhuys, W. J.; Lockman, P. R. Exploiting Nutrient Transporters at the Blood-Brain Barrier to Improve Brain Distribution of Small Molecules Ther. Delivery 2010, 1, 775-784 10.4155/tde.10.76
6. Daniels, T. R.; Bernabeu, E.; Rodriguez, J. A.; Patel, S.; Kozman, M.; Chiappetta, D. A.; Holler, E.; Ljubimova, J. Y.; Helguera, G.; Penichet, M. L. The Transferrin Receptor and the Targeted Delivery of Therapeutic Agents against Cancer Biochim. Biophys. Acta, Gen. Subj. 2012, 1820, 291-317 10.1016/j.bbagen.2011.07.016
7. Blanco, E.; Shen, H.; Ferrari, M. Principles of Nanoparticle Design for Overcoming Biological Barriers to Drug Delivery Nat. Biotechnol. 2015, 33, 941-951 10.1038/nbt.3330
8. Doshi, N.; Prabhakarpandian, B.; Rea-Ramsey, A.; Pant, K.; Sundaram, S.; Mitragotri, S. Flow and Adhesion of Drug Carriers in Blood Vessels Depend on Their Shape: A Study Using Model Synthetic Microvascular Networks J. Controlled Release 2010, 146, 196-200 10.1016/j.jconrel.2010.04.007
9. Arslan, O. Neuroanatomical Basis of Clinical Neurology, 2nd ed.; CRC Press: 2015.
10. Bae, Y. H.; Park, K. Targeted Drug Delivery to Tumors: Myths, Reality and Possibility J. Controlled Release 2011, 153, 198-205 10.1016/j.jconrel.2011.06.001
11. Wang, J.; Huang, Y.; David, A. E.; Chertok, B.; Zhang, L.; Yu, F.; Yang, V. C. Magnetic Nanoparticles for MRI of Brain Tumors Curr. Pharm. Biotechnol. 2012, 13, 2403-2416 10.2174/138920112803341824
12. Pedram, M. Z.; Shamloo, A.; Alasty, A.; Ghafar-Zadeh, E. Toward Epileptic Brain Region Detection Based on Magnetic Nanoparticle Patterning Sensors 2015, 15, 24409-24427 10.3390/s150924409
13. Moos, T.; Morgan, E. H. Transferrin and Transferrin Receptor Function in Brain Barrier Systems Cell. Mol. Neurobiol. 2000, 20, 77-95 10.1023/A:1006948027674
14. Lee, J. H.; Engler, J. A.; Collawn, J. F.; Moore, B. A. Receptor Mediated Uptake of Peptides that Bind the Human Transferrin Receptor Eur. J. Biochem. 2001, 268, 2004-2012 10.1046/j.1432-1327.2001.02073.x
15. Liu, Q.; Zhang, J.; Xia, W.; Gu, H. Magnetic Field Enhanced Cell Uptake Efficiency of Magnetic Silica Mesoporous Nanoparticles Nanoscale 2012, 4, 3415-3421 10.1039/c2nr30352c
16. Cheng, Z.; Dai, Y.; Kang, X.; Li, C.; Huang, S.; Lian, H.; Hou, Z.; Ma, P.; Lin, J. Gelatin-Encapsulated Iron Oxide Nanoparticles for Platinum (IV) Prodrug Delivery, Enzyme-Stimulated Release and MRI Biomaterials 2014, 35, 6359-6368 10.1016/j.biomaterials.2014.04.029
17. Chan, N.; Laprise-Pelletier, M.; Chevallier, P.; Bianchi, A.; Fortin, M. A.; Oh, J. K. Multidentate Block-Copolymer-Stabilized Ultrasmall Superparamagnetic Iron Oxide Nanoparticles with Enhanced Colloidal Stability for Magnetic Resonance Imaging Biomacromolecules 2014, 15, 2146-2156 10.1021/bm500311k
18. Corot, C.; Robert, P.; Idee, J. M.; Port, M. Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging Adv. Drug Delivery Rev. 2006, 58, 1471-1504 10.1016/j.addr.2006.09.013
19. Li, J.; Zhang, C.; Yang, K.; Liu, P.; Xu, L. X. SPIO-RGD Nanoparticles as A Molecular Targeting Probe for Imaging Tumor Angiogenesis Using Synchrotron Radiation J. Synchrotron Radiat. 2011, 18, 612-616 10.1107/S090904951101017X
20. Liang, J. M.; Zeng, F.; Zhang, M.; Pan, Z. Z.; Chen, Y. Z.; Zeng, Y. N.; Xu, Y.; Xu, Q.; Huang, Y. Z. Green Synthesis of Hyaluronic Acid-Based Silver Nanoparticles and Their Enhanced Delivery to CD44(+) Cancer Cells RSC Adv. 2015, 5, 43733-43740 10.1039/C5RA03083H
21. Ling, Y. H.; el-Naggar, A. K.; Priebe, W.; Perez-Soler, R. Cell Cycle-Dependent Cytotoxicity, G2/M Phase Arrest, and Disruption of P34cdc2/Cyclin B1 Activity Induced by Doxorubicin in Synchronized P388 Cells Mol. Pharmacol. 1996, 49, 832-841
22. Bar-On, O.; Shapira, M.; Hershko, D. D. Differential Effects of Doxorubicin Treatment on Cell Cycle Arrest and Skp2 Expression in Breast Cancer Cells Anti-Cancer Drugs 2007, 18, 1113-1121 10.1097/CAD.0b013e3282ef4571
23. Rafehi, H.; Orlowski, C.; Georgiadis, G. T.; Ververis, K.; El-Osta, A.; Karagiannis, T. C. Clonogenic Assay: Adherent Cells J. Visualized Exp. 2011, 10.3791/2573
24. Zhang, J.; Chen, N.; Wang, H.; Gu, W.; Liu, K.; Ai, P.; Yan, C.; Ye, L. Dual-Targeting Superparamagnetic Iron Oxide Nanoprobes with High and Low Target Density for Brain Glioma Imaging J. Colloid Interface Sci. 2016, 469, 86-92 10.1016/j.jcis.2016.02.004
25. Gao, H. Perspectives on Dual Targeting Delivery Systems for Brain Tumors J. Neuroimmune Pharmacol. 2016, 1-11 10.1007/s11481-016-9687-4
26. Cui, Y.; Xu, Q.; Chow, P. K.; Wang, D.; Wang, C. H. Transferrin-Conjugated Magnetic Silica PLGA Nanoparticles Loaded with Doxorubicin and Paclitaxel for Brain Glioma Treatment Biomaterials 2013, 34, 8511-8520 10.1016/j.biomaterials.2013.07.075
27. Fang, J. H.; Chiu, T. L.; Huang, W. C.; Lai, Y. H.; Hu, S. H.; Chen, Y. Y.; Chen, S. Y. Dual-Targeting Lactoferrin-Conjugated Polymerized Magnetic Polydiacetylene-Assembled Nanocarriers with Self-Responsive Fluorescence/Magnetic Resonance Imaging for In Vivo Brain Tumor Therapy Adv. Healthcare Mater. 2016, 5, 688-695 10.1002/adhm.201500750
28. Fang, J. H.; Lai, Y. H.; Chiu, T. L.; Chen, Y. Y.; Hu, S. H.; Chen, S. Y. Magnetic Core-Shell Nanocapsules with Dual-Targeting Capabilities and Co-Delivery of Multiple Drugs to Treat Brain Gliomas Adv. Healthcare Mater. 2014, 3, 1250-1260 10.1002/adhm.201300598
29. Mody, V. V.; Cox, A.; Shah, S.; Singh, A.; Bevins, W.; Parihar, H. Magnetic Nanoparticle Drug Delivery Systems for Targeting Tumor Appl. Nanosci. 2014, 4, 385-392 10.1007/s13204-013-0216-y
30. Patil, U. S.; Adireddy, S.; Jaiswal, A.; Mandava, S.; Lee, B. R.; Chrisey, D. B. In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles Int. J. Mol. Sci. 2015, 16, 24417-24450 10.3390/ijms161024417
31. Singh, N.; Jenkins, G. J.; Asadi, R.; Doak, S. H. Potential Toxicity of Superparamagnetic Iron Oxide Nanoparticles (SPION). Nano Rev. 2010, 1, 10.3402/nano.v1i0.5358
32. Min, K. A.; Shin, M. C.; Yu, F.; Yang, M.; David, A. E.; Yang, V. C.; Rosania, G. R. Pulsed Magnetic Field Improves the Transport of Iron Oxide Nanoparticles Through Cell Barriers ACS Nano 2013, 7, 2161-2171 10.1021/nn3057565
33. Min, K. A.; Yu, F.; Yang, V. C.; Zhang, X.; Rosania, G. R. Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field Pharmaceutics 2010, 2, 119-135 10.3390/pharmaceutics2020119
34. Dang, Y. P.; Yuan, X. Y.; Tian, R.; Li, D. G.; Liu, W. Curcumin Improves the Paclitaxel-Induced Apoptosis of HPV-Positive Human Cervical Cancer Cells via the NF-KappaB-P53-Caspase-3 Pathway Exp. Ther. Med. 2015, 9, 1470-1476 10.3892/etm.2015.2240
35. Ganta, S.; Amiji, M. Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations to Overcome Multidrug Resistance in Tumor Cells Mol. Pharmaceutics 2009, 6, 928-939 10.1021/mp800240j
36. Hossain, M.; Banik, N. L.; Ray, S. K. Synergistic anti-Cancer Mechanisms of Curcumin and Paclitaxel for Growth Inhibition of Human Brain Tumor Stem Cells and LN18 and U138MG Cells Neurochem. Int. 2012, 61, 1102-1113 10.1016/j.neuint.2012.08.002